Orbillion Achieves Multicontinental Production Milestone for Cultivated Beef

Orbillion has achieved a significant milestone in the cultivated meat sector by successfully producing beef muscle cells at manufacturing facilities in North America, Europe, and Asia. This advancement marks a key development in scaling cultivated meat for global markets while addressing challenges related to cost and large-scale production. Dr. Thomas Beck has been appointed to the Board of Directors to further accelerate commercialization efforts, bringing over 30 years of expertise in food technology to guide Orbillion towards broader market readiness.

Orbillion's innovative approach to cultivated meat sets it apart from competitors by using proprietary computational tools and "bioware" to directly scale beef muscle and fat cells without genetic modification. This method has significantly reduced development costs and production timelines. The company's focus on scaling production ensures readiness to meet market demand once regulatory approvals are in place, despite hurdles in the cultivated meat industry. Orbillion aims to deliver sustainable and cost-effective cultivated meat to consumers worldwide, revolutionizing the future of food.